[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "BNT162b3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "BNT162b3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "Escalating dose levels;Anti-viral RNA vaccine for active immunization against COVID-19 administered as intramuscular injection (Prime/Boost (P/B) regimen);\u22651;Part A participants aged 18 to 55 years.", "treatment_id": 224, "treatment_name": "Bnt162b3", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Escalating dose levels;Anti-viral RNA vaccine for active immunization against COVID-19 administered as intramuscular injection (Prime/Boost (P/B) regimen);\u22651;Part A participants aged 56 to 85 years (optional).", "treatment_id": 224, "treatment_name": "Bnt162b3", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]